You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A central aortic pulse wave velocity measurement device

    SBC: Cardiovascular Engineering, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Increased stiffness of large central conduit vessels has recently emerged as an important risk factor for cardiovascular disease. Abnormalities in conduit vessel stiffness are highly prevalent and are associated wi

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  2. Acetylator-based Individualized Dosing of Amonadife

    SBC: XANTHUS LIFE SCIENCES, INC.            Topic: N/A

    Chemotherapeutic dosing has traditionally been empiric, with all patients receiving the same dose adjusted for body surface area (BSA). Unfortunately, while this may be adequate for the average person, it can be inappropriate for the majority of patien

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  3. A Dual Molecular/Tumor Targeting Therapy for PanCa

    SBC: SYNERGENE THERAPEUTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Approximately 30,000 people in the United States are diagnosed each year with pancreatic cancer (PanCa). Over 90% of these will die of the disease making PanCa one of the most devastating human malignancies. The c

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  4. Advancing a Glioma Immunotherapy

    SBC: IN CYTU, INC.            Topic: 102

    DESCRIPTION provided by applicant A Phase II SBIR program of preclinical development is proposed for the development of an active specific immunotherapeutic called Cellariumandquot for treatment of glial cell based cancers Successful completion of this project will confirm therapeutic effect and pre clinical safety of the vaccine in preparation for first in human studies Upon demonstration of ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  5. Afterglow CsI(Tl) Scintillator for Medical Applications

    SBC: RADIATION MONITORING DEVICES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): CsI doped with thallium is one of the most important scintillators currently in use. In terms of conversion of ionizing radiation to visible photons, it is the unquestioned leader in efficiency. Additionally, its hi

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  6. A Hand-Held System for Live Anthrax Spore Detection

    SBC: IQUUM, INC.            Topic: N/A

    DESCRIPTION (provided by investigator): A 2002 government study on the accuracy of field tests for anthrax spores casts serious doubt on the validity of these tests. Moreover, one of the DNA markers still being used in some commercial kits was shown to a

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  7. An all-optical electrophysiology platform for the discovery of pain therapeutics

    SBC: Q-State Biosciences, Inc.            Topic: 103

    Project Summary Chronic pain affects over 100 million adults in the United States and is challenging to treat. Current treatments include opioids and non-steroidal inflammatory agents. However, efficacy of these drugs in chronic treatment is restricted by dose limiting toxicities, and prolonged opioid use can lead to dependency. Despite the clear, unmet medical need and significant research activi ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  8. An automated platform for direct-from-specimen identification of pathogens common in endocarditis

    SBC: HELIXBIND, INC.            Topic: NIAID

    PROJECT SUMMARY Infective Endocarditis (IE) is a life-threatening disease that affects roughly 45,000 Americans annually. IE is characterized by microbial vegetations on the endocardial surface which induce serious heart damage and persistent bloodstream infections (BSIs) leading to sepsis. Left untreated IE is fatal. Among the criteria to establish IE and treat patients most effectively, blood cu ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  9. An automated test for gestational diabetes based on glycated CD59

    SBC: Mellitus, LLC            Topic: 200

    Diabetes and pre-Diabetes are growing at an epidemic rate. Mellitus, LLC is developing a novel test for Gestational Diabetes (GDM) and Diabetes based on the novel biomarker, Glycated CD59 (GCD59), licensed exclusively to Mellitus from Harvard University. With nearly 4M annual pregnancies in the US and 130MM live births worldwide, GDM is a high public health priority because it is a major cause of ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  10. A New Scintillator for Nuclear Medicine Imaging

    SBC: RADIATION MONITORING DEVICES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Nuclear medicine imaging modalities such as single photon emission computed tomography (SPECT) and positron emission tomography (PET) are powerful, non-invasive medical imaging techniques that provide an image of th

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government